Control Bionics Limited (CBL.AX)
AUD 0.05
(2.22%)
AUD 0.05
(2.22%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -19.02 Thousand AUD | 97.64% |
| 2023 | -807 Thousand AUD | 83.63% |
| 2022 | -4.92 Million AUD | 59.98% |
| 2021 | -12.31 Million AUD | 20.8% |
| 2020 | -15.55 Million AUD | -1846.46% |
| 2019 | -798.88 Thousand AUD | 56.55% |
| 2018 | -1.83 Million AUD | 99.49% |
| 2017 | -363.81 Million NZD | -57.64% |
| 2016 | -230.79 Million NZD | -44.67% |
| 2015 | -159.53 Million NZD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -463.62 Thousand AUD | 62.47% |
| 2024 Q2 | -1.23 Million AUD | 2.54% |
| 2024 Q4 | -19.02 Thousand AUD | 95.9% |
| 2024 FY | -19.02 Thousand AUD | 97.64% |
| 2024 Q1 | -1.26 Million AUD | -57.08% |
| 2023 Q2 | -2.84 Million AUD | 3.54% |
| 2023 Q4 | -807 Thousand AUD | 13.74% |
| 2023 FY | -807 Thousand AUD | 83.63% |
| 2023 Q3 | -935.5 Thousand AUD | 67.09% |
| 2023 Q1 | -2.94 Million AUD | 40.22% |
| 2022 FY | -4.92 Million AUD | 59.98% |
| 2022 Q4 | -4.92 Million AUD | 2.22% |
| 2022 Q3 | -5.04 Million AUD | 37.21% |
| 2022 Q2 | -8.02 Million AUD | 1.22% |
| 2022 Q1 | -8.12 Million AUD | 34.0% |
| 2021 Q1 | 1.42 Million AUD | 224.64% |
| 2021 FY | -12.31 Million AUD | 20.8% |
| 2021 Q4 | -12.31 Million AUD | 0.12% |
| 2021 Q3 | -12.33 Million AUD | 14.75% |
| 2021 Q2 | -14.46 Million AUD | -1112.68% |
| 2020 Q4 | -1.14 Million AUD | 0.0% |
| 2020 FY | -15.55 Million AUD | -1846.46% |
| 2019 FY | -798.88 Thousand AUD | 56.55% |
| 2018 FY | -1.83 Million AUD | 99.49% |
| 2017 FY | -363.81 Million NZD | -57.64% |
| 2017 Q2 | -363.81 Million NZD | 0.0% |
| 2016 FY | -230.79 Million NZD | -44.67% |
| 2015 FY | -159.53 Million NZD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 99.925% |
| Adherium Limited | -6.1 Million AUD | 99.688% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 99.492% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 99.472% |
| Anteris Technologies Ltd | -28.49 Million AUD | 99.933% |
| CardieX Limited | 2.74 Million AUD | 100.693% |
| Compumedics Limited | 5.08 Million AUD | 100.374% |
| Cochlear Limited | -269.9 Million AUD | 99.993% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 102.723% |
| Cyclopharm Limited | -7.49 Million AUD | 99.746% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 99.879% |
| Nova Eye Medical Limited | -2.8 Million AUD | 99.321% |
| HeraMED Limited | -799.34 Thousand AUD | 97.62% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 100.131% |
| ImpediMed Limited | -23.48 Million AUD | 99.919% |
| InhaleRx Limited | -155.54 Thousand AUD | 87.771% |
| LBT Innovations Limited | -604 Thousand AUD | 96.851% |
| Micro-X Limited | 826.99 Thousand AUD | 102.3% |
| Neurotech International Limited | -2.11 Million AUD | 99.099% |
| OncoSil Medical Limited | -4.43 Million AUD | 99.571% |
| PolyNovo Limited | -30.52 Million AUD | 99.938% |
| Respiri Limited | 413.68 Thousand AUD | 104.598% |
| SomnoMed Limited | -15.16 Million AUD | 99.875% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 99.641% |
| Uscom Limited | -1.53 Million AUD | 98.757% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 99.534% |